Corona Remedies

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE02ZQ01018
  • NSEID: CORONA
  • BSEID: 544644
INR
1,829.40
37.05 (2.07%)
BSENSE

Jun 18

BSE+NSE Vol: 1.71 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Marksans Pharma
Sanofi Consumer
Akums Drugs
Corona Remedies
Sudeep Pharma
Viyash Scientifi
Strides Pharma
Alivus Life
Shilpa Medicare
P & G Health Ltd
Blue Jet Health
Why is Corona Remedies Ltd ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Corona Remedies should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
27.90
Debt to EBITDA (avg)
0.56
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.54
Tax Ratio
23.03%
Dividend Payout Ratio
30.00%
Pledged Shares
0
Institutional Holding
9.26%
ROCE (avg)
29.49%
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
56
Industry P/E
34
Price to Book Value
15.00
EV to EBIT
44.25
EV to EBITDA
38.54
EV to Capital Employed
13.05
EV to Sales
8.06
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
29.49%
ROE (Latest)
26.75%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
Bullish
OBV
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
PAT(Latest six months)

At Rs 100.88 cr has Grown at 31.87%

-2What is not working for the Company
PBT LESS OI(Q)

At Rs 50.63 cr has Fallen at -15.8% (vs previous 4Q average

Loading Valuation Snapshot...
Here's what is working for Corona Remedies
Profit After Tax (PAT) - Latest six months
At Rs 100.88 cr has Grown at 31.87%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Here's what is not working for Corona Remedies
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 50.63 cr has Fallen at -15.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 60.11 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Non Operating Income - Quarterly
Highest at Rs 4.11 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."